Rafi Ahmed

Last updated

Rafi Ahmed
Rafi Ahmed virologist and immunologist.jpg
Born1948 (age 7475)
Alma mater Harvard University
ChildrenHasan Ahmed, Fatima Ahmed
AwardsMember of the National Academy of Sciences since 2009, received American Association of Immunologists' Excellence in Mentoring Award in 2015 [1]
William B. Coley Award (2017)
Scientific career
Fields Microbiology, immunology
Patrons Pallotta TeamWorks [2]
Thesis Genetic Studies Of Persistent Reovirus Infection In L Cells  (1981)
Notable students Shane Crotty (postdoc)

Rafi Ahmed (born 1948 in Hyderabad, India) is an Indian-American virologist and immunologist. He is the Charles Howard Candler Professor of Microbiology and Immunology at Emory University, where he is also the director of the Emory Vaccine Center and a Georgia Research Alliance Eminent Scholar in Vaccine Research. In 2009, he was elected to the National Academy of Sciences. [3]

Contents

Early life and education

Ahmed was born and raised in Hyderabad, India, where his father served as a public servant and his mother as an active volunteer. While living in Hyderabad, Ahmed received his BSc in chemistry from Osmania University in 1968. With strong English skills from his school in India, Ahmed moved in 1970 to Pocatello, Idaho to attend Idaho State University, where he received another B.S. in 1972 and an M.S. in 1974, both of which were in microbiology. He then attended McGill University, originally with the goal of receiving a doctorate in microbiology, but, after questioning his motivation for the field, he dropped out of McGill and later worked as a research assistant there for two years. In 1981, he received his Ph.D. in microbiology from Harvard University after studying for four years in Bernard Fields's lab. Later that year, he left Harvard for the Scripps Institute to begin his postdoc. [4]

Career

After completing his postdoc in 1984, Ahmed joined the University of California, Los Angeles (UCLA) as an assistant professor. In 1992, he became a full professor there. In 1995, he left UCLA and joined the faculty at Emory as a Georgia Research Alliance Eminent Scholar in Vaccine Research and the director of the Emory Vaccine Center, positions he has held ever since. After serving as a professor of microbiology and immunology at Emory for 15 years, Ahmed was named to the Charles Howard Candler Professorship of microbiology and immunology there in 2010. [4] He also served on the Life Sciences jury for the Infosys Prize in 2010. Ahmed currently serves as the Vaccine Center director, professor of microbiology and immunology, and AIDS research investigator at Emory University in Atlanta, Georgia.

Research

Ahmed is known for his research on T cells, which he began studying during his postdoc. [4] Specifically, at UCLA, Ahmed studied memory T cell differentiation and immunity of T and B cells against viruses, such as hepatitis C and HIV in a paper that gained him notoriety in the immunology world. [5] [6] In 1995, Ahmed moved to Emory University and began his work to secure funding to develop a vaccine center there. At Emory, Ahmed has worked to investigate t-cell exhaustion in fighting chronic infection, through which he discovered a link between t-cell exhaustion and expression of the gene PD1, or "Programmed Death 1." With the help of Emory graduate student Daniel Barber, Ahmed devised a way to use antibodies to block this inhibitory receptor and enhance flagging T-cell function. Today, "PD1 Blockade Treatments" are being investigated for treating aggressive cancers with promising preliminary results. At the Ahmed Laboratory at Emory University, Rafi Ahmed and his team work to build understanding on the development and maintenance of humoral memory. The lab has co-developed a novel method for rapidly generating human monoclonal antibodies after vaccination, and has shown that "broadly cross-reactive antibodies that recognize multiple influenza viruses can be generated after influenza vaccination in humans." [5] This research is reportedly paving the way for a possible future universal influenza vaccine.

Related Research Articles

Ellen S. Vitetta is the director of the Cancer Immunobiology Center at the University of Texas Southwestern Medical Center in Dallas.

Gordon Leslie Ada AO, FAA was an Australian biochemist best known for his seminal contributions to virology and immunology and his long leadership of the Department of Microbiology at the John Curtin School of Medical Research at the Australian National University, where Peter C. Doherty and Rolf Zinkernagel performed their Nobel winning research in his department. Both Zinkernagel and Doherty held him in high regard, and he was invited by them to attend the Nobel award ceremony and dinner in Stockholm.

<span class="mw-page-title-main">Elvin A. Kabat</span> American biomedical scientist

Elvin Abraham Kabat was an American biomedical scientist and one of the founding fathers of quantitative immunochemistry. Kabat was awarded the Louisa Gross Horwitz Prize from Columbia University in 1977, National Medal of Science in 1991, and American Association of Immunologists Lifetime Achievement Award in 1995. He is the father of Jon Kabat-Zinn.

<span class="mw-page-title-main">Marian Koshland</span> American immunologist (1921–1997)

Marian Elliott "Bunny" Koshland was an American immunologist who discovered that the differences in amino acid composition of antibodies explain the efficiency and effectiveness with which they combat a huge range of foreign invaders.

Barton Ford Haynes is an American physician and immunologist internationally recognized for work in T-cell immunology, retrovirology, and HIV vaccine development. Haynes is a Frederic M. Hanes Professor of Medicine and Immunology at Duke University Medical Center. He is the director of the Duke Human Vaccine Institute and the Duke Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVI-ID), which was funded by the National Institute of Allergy and Infectious Diseases (NIAID) in 2012. In addition, Haynes directs the B-cell Lineage Envelope Design Study, the Centralized Envelope Phase I Study, and the Role of IgA in HIV-1 Protection Study as part of the Collaboration for AIDS Vaccine Discovery (CAVD), which was funded by the Bill and Melinda Gates Foundation in 2006.

J. (Joseph) Donald Capra is an American immunologist, physician-scientist, and was the 4th full-time president (1997–2007) and later, president emeritus, of the Oklahoma Medical Research Foundation (OMRF) in Oklahoma City, OK. While president, he helped to raise over $100 million and spearheaded major research growth in grants funded and faculty recruited to the institution.

Ronald C. Kennedy was a virus immunologist at Texas Tech University. Prior to his appointment there he was affiliated with Baylor University, where he had previously done postdoctoral studies. Furthermore, when he switched affiliations to Texas Tech, he was also an adjunct, associate and full professor in the Departments of Microbiology and Pediatrics at the University of Texas Health Science Center at San Antonio. After his tenure in San Antonio, he switched affiliations to the University of Oklahoma Health Sciences Center's department of microbiology and immunology. In the 1980s he was affiliated with the Southwest Foundation for Biomedical Research, during which time he published some research pertaining to SV40 and intracellular protein transport. More recently, Kennedy has published some research regarding DNA vaccination, mostly in the journal Cancer Immunology, Immunotherapy.

<span class="mw-page-title-main">Max Dale Cooper</span> American immunologist

Max Dale Cooper, is an American immunologist and a professor at the Department of Pathology and Laboratory Medicine and the Emory Vaccine Center of Emory University School of Medicine. He is known for characterizing T cells and B cells.

<span class="mw-page-title-main">Akiko Iwasaki</span> Immunobiologist

Akiko Iwasaki is a Sterling Professor of Immunobiology and Molecular, Cellular and Developmental Biology at Yale University. She is also a principal investigator at the Howard Hughes Medical Institute. Her research interests include innate immunity, autophagy, inflammasomes, sexually transmitted infections, herpes simplex virus, human papillomavirus, respiratory virus infections, influenza infection, T cell immunity, commensal bacteria, COVID-19 and Long COVID.

<span class="mw-page-title-main">Holger Lode</span> German specialist for pediatrics (born 1967)

Holger Lode is a German specialist for pediatrics. He is Professor and Chair of the Department of General Pediatrics and Pediatric Hematology and Oncology at the University Medicine Greifswald. He is also the director of the Center of Pediatrics and Adolescent Medicine in Greifswald. Lode is well known for his clinical and scientific work on immunotherapy of neuroblastoma.

Herman Nathaniel Eisen was an American immunologist and cancer researcher. He served on the faculty at New York University School of Medicine in the early 1950s, became the Chief of Dermatology at the Washington University School of Medicine in 1955, and was a founding member of the MIT Center for Cancer Research. Eisen retired and assumed professor emeritus status in 1989, but continued to be active as a researcher; he was working on a manuscript the day he died in 2014.

Gary J. Nabel is an American virologist and immunologist, and President and chief executive officer of ModeX Therapeutics in Natick, Massachusetts.

<span class="mw-page-title-main">Andrew McMichael</span>

Sir Andrew James McMichael, is an immunologist, Professor of Molecular Medicine, and previously Director of the Weatherall Institute of Molecular Medicine at the University of Oxford. He is particularly known for his work on T cell responses to viral infections such as influenza and HIV.

Shane Patrick Crotty is a professor of immunology in the Center for Infectious Disease and Vaccine Research at La Jolla Institute for Immunology.

Garnett Herrel Kelsoe is an American immunologist and the James B. Duke Professor of Immunology at Duke University School of Medicine.

James Earl Crowe Jr. is an American immunologist and pediatrician as well as Professor of Pediatrics and Pathology, Microbiology, and Immunology at Vanderbilt University Medical Center.

Edward John Wherry III is an American immunologist. He is the Richard and Barbara Schiffrin President's Distinguished Professor and department chair of Systems Pharmacology and Translational Therapeutics at the University of Pennsylvania. He is also the director of the Penn Institute for Immunology.

Michael Joseph Mina is an American epidemiologist, immunologist and physician. He was formerly an assistant professor of Epidemiology & Immunology and Infectious Diseases at Harvard T.H. Chan School of Public Health, assistant Professor of Pathology at Brigham and Women's Hospital, Harvard Medical School, and currently Chief Medical Officer at eMed.

<span class="mw-page-title-main">Paul Fiset</span> Canadian-American microbiologist (1922–2001)

Paul Fiset was a Canadian-American microbiologist and virologist. His research helped to develop one of the first successful Q fever vaccines, noted by The New York Times. Fiset was born in Quebec, Canada, and attended Laval University, where he earned a Doctor of Medicine degree in 1949. He subsequently attended Cambridge University, where he received a PhD degree in 1956. As a professor at the University of Maryland School of Medicine, he also researched other bacterial diseases such as typhus and Rocky Mountain spotted fever, in addition to Q fever.

Harriet Latham Robinson is an American vaccine researcher who is founder and Chief Scientific Officer at GeoVax. She is the former Asa Griggs Candler Professor of Microbiology at Emory University. Her research considered HIV vaccine development. She is a Fellow of the American Association for the Advancement of Science.

References

  1. "Rafi Ahmed". The American Association of Immunologists. 28 February 2021. Archived from the original on 28 February 2021. Retrieved 28 February 2021.
  2. Harbert, Nancy (18 November 2002). "Riding Your Heart Out, Then Feeling Betrayed". The New York Times.
  3. "Rafi Ahmed". Member Directory. National Academy of Sciences.
  4. 1 2 3 "Biography of Rafi Ahmed". Game Changers. Emory University.
  5. 1 2 "Rafi Ahmed". Emory Vaccine Center. Emory University. Archived from the original on 30 November 2017. Retrieved 24 March 2017.
  6. McNeil, Donald (20 December 2010). "Five Years In, Gauging Impact of Gates Grants". The New York Times.